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Differential Regulation of Karyopherin a 2 Expression
by TGF-b1 and IFN-c in Normal Human Epidermal
Keratinocytes: Evident Contribution of KPNA2 for
Nuclear Translocation of IRF-1
Noriko Umegaki1,3, Katsuto Tamai2, Hajime Nakano1, Ryuta Moritsugu1, Takehiko Yamazaki2, Katsumi
Hanada1, Ichiro Katayama3 and Yasufumi Kaneda2
Despite a number of studies on signal transduction in epidermal keratinocytes, very little is known about how
signals move from the cytosole to the nucleus during the course of keratinocyte proliferation and
differentiation. In this study, we first compared the expression patterns of the karyopherin a (KPNA) subtypes,
and found that KPNA2, KPNA3, and KPNA4 were the major subtypes in both normal human epidermal
keratinocytes (NHEKs) and normal human dermal fibroblasts (NHDFs). Stimulation with either transforming
growth factor (TGF)-b1 or IFN-g for 24 hours resulted in the downregulation of KPNA2 expression specifically in
NHEK at both the mRNA and protein levels. Interestingly, IFN-g, but not TGF-b1, specifically downregulated
KPNA2 expression at the promoter level, suggesting differential regulation of KPNA2 expression by IFN-g and
TGF-b1. We then demonstrated that KPNA2 physically bound to IFN regulatory factor-1 (IRF-1), a transcription
factor induced by IFN-g, and induced nuclear translocation of IRF-1 in NHEKs. We finally performed microarray
and quantitative real-time PCR analysis for the mRNA expression pattern of NHEK with either overexpression or
knockdown of KPNA2, and indicated KPNA2 involvement for various epidermal gene regulations such as
involucrin. Our data suggest that KPNA2 may play an important role in the signal-transduction pathways that
regulate epidermal proliferation and differentiation.
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INTRODUCTION
Recent reports have indicated that there are multiple pathways
for nucleocytoplasmic protein transport, which involve
specific transporters recognizing specific sequences in target
proteins, such as nuclear localization signals (NLSs). The NLS
protein–receptor complex is then transported through the
nuclear pore in an energy-dependent manner (Goldfarb et al.,
2004; Pemberton and Paschel, 2005). The importin/karyo-
pherin superfamily consists of cytosolic receptors that recog-
nize NLSs and dock the NLS-containing proteins at the nuclear
pore complex on the nuclear membrane. Members of the
karyopherin a (KPNA) family interact specifically with
karyopherin b1 to form karyopherin a–b heterodimers, which
affect the receptors’ affinity for NLSs and docking at the
nuclear pore complex. At least six KPNA isoforms have been
reported to be ubiquitously expressed in human cells (Quensel
et al., 2004): KPNA1/importin a5 (Cortes et al., 1994; O’Neil
and Palese, 1995), KPNA2/importin a1 (Cuomo et al., 1994;
Weis et al., 1995; Guillemain et al., 2002), KPNA3/importin
a4 (Ko¨hler et al., 1997; Takeda et al., 1997; Nachury et al.,
1998), KPNA4/importin a3 (Ko¨hler et al., 1997; Seki et al.,
1997), KPNA5/importin a6 (Ko¨hler et al., 1997), and KPNA6/
importin a7 (Ko¨hler et al., 1997; Tsuji et al., 1997). The
different KPNA proteins show distinct NLS-binding specificities
(Nadler et al., 1997; Ko¨hler et al., 1999), and members of this
gene family exhibit selective expression in various tissues at
both the mRNA and protein levels (Takeda et al., 1997;
Nachury et al., 1998; Ko¨hler et al., 2002). There are, however,
few reports concerning the expression and function of
particular KPNA isoforms in the skin. Moreover, whether
there are specific roles for each KPNA isoform during signal
transduction in various tissues, including the skin, has not yet
been determined.
Epidermal keratinocytes regulate their proliferation and
differentiation by transducing signals from outside the cell
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membrane to the nucleus through nuclear pores, thereby
regulating the expression of epidermal proliferation- and
differentiation-specific genes. To maintain epidermal homeo-
stasis and to respond to pathogenic processes, such as
wounds or inflammatory conditions, entry of the signal
mediators into the nucleus seems to be tightly regulated by
KPNAs. This suggests that each KPNA may have a unique set
of target proteins, although the precise mechanism has not
been identified.
Here we report the first examination of the expression
patterns of KPNAs in normal human epidermal keratinocytes
(NHEKs) and normal human dermal fibroblasts (NHDFs). In
this study, we determined that KPNA2 expression in NHEKs,
but not in NHDFs, is differentially regulated by trans-
forming growth factor (TGF)-b1 and IFN-g, both of which
are established modulators of epidermal proliferation
and differentiation. We also provide evidence that KPNA2
may mediate the translocation of epidermal differentia-
tion-inducing signals into the nucleus, at least in part, by
recruiting transcription factors such as IFN regulatory
factor-1 (IRF-1), a mediator of IFN-g-induced epidermal
differentiation (Odanagi et al., 2004). The data shown
here provide novel insights into the signal transduction
in epidermal keratinocytes mediated by the nuclear trans-
porter KPNA2.
RESULTS
Expression patterns of KPNA mRNAs in NHEK, HaCaT,
and NHDF cells
The expressions of KPNA1, KPNA2, KPNA3, and KPNA4
mRNAs were detected in NHEK, HaCaT, and NHDF cells by
Northern blot analysis. KPNA5 mRNA, however, did not
produce sufficiently strong signals using this method, and
was detected only by reverse transcription (RT)-PCR. In
all three cell types, KPNA2, KPNA3, and KPNA4 seemed
to be strongly expressed, whereas KPNA1 and KPNA5
were expressed with relatively low signals (Figure 1). After
correction with the glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH) expression level, relative mRNA expression
levels of KPNA1 and KPNA2 in NHEK cells were stronger
than in NHDF cells.
Downregulation of KPNA2 mRNA expression by TGF-b1
in NHEK cells
TGF-b1 treatment (5 ng/ml) of NHEK cells resulted in the
selective and time-dependent downregulation of KPNA2
mRNA expression; a nearly 70% inhibition was observed
after 24 hours (Po0.001) (Figure 2a). Moreover, this TGF-b1-
mediated inhibition was found to be dose dependent; an
approximately 50% inhibition was observed after 24 hours
with a dose of 5 ng/ml TGF-b1 (Po0.001). At a dose of 10 ng/
ml TGF-b1, however, the KPNA2 mRNA level was not
significantly different from that observed at a dose of 5 ng/ml.
On the contrary, there were no remarkable changes in the
KPNA2 mRNA levels in NHDF cells (Figure 2a and b). The
addition of cycloheximide (CHX) to the culture medium
antagonized the effects of TGF-b1 on KPNA2 mRNA
expression in NHEK cells (Figure 2c). For the other members
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Figure 1. Expression patterns of KPNA mRNAs in NHEK, HaCaT, and NHDF
cells. mRNA extracted from sub-confluent NHEK, HaCaT, and NHDF cells
was subjected to Northern blot analysis for the human KPNA1, KPNA2,
KPNA3, KPNA4, KPNA5, and GAPDH genes. Exposure time: KPNA2,
KPNA3, and KPNA4 for 24 hours; KPNA1 and KPNA5 for 7 days. Data are
representative of two independent experiments.
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Figure 2. Specific regulation of KPNA2 mRNA expression by TGF-b1 in
NHEK cells. (a) Time-course analysis of KPNA2 mRNA expression regulated
by TGF-b1 in NHEK and NHDF cells. (b) Dose analysis of KPNA2 mRNA
expression was obtained after 24-hour incubations with TGF-b1 in NHEK and
NHDF cells. (c) Downregulation of KPNA2 mRNA expression by TGF-b1
(5 ng/ml) was antagonized by CHX treatment (10 mg/ml), which started 1 hour
before TGF-b1 administration. Data are expressed as means7SD from three
independent experiments (*Po0.05 and **Po0.01 compared with the initial
expression level by one-way ANOVA).
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of the KPNA family, no significant changes in mRNA
expression levels were observed following TGF-b1 stimula-
tion (data not shown).
Dual modulation of KPNA2 mRNA expression by
IFN-c in NHEKs
Stimulation of NHEKs with 100 U/ml IFN-g specifically
upregulated KPNA2 mRNA expression within 12 hours
(Figure 3a). The maximal expression level, which was
approximately twice the initial expression level, was ob-
served after 6-hour incubation (Po0.001). The expression
level then gradually declined to about 40% of the initial
expression level (Po0.05) after 48 hours, suggesting
dual regulation of KPNA2 by IFN-g. Stimulation of cells
with various concentrations of IFN-g for 48 hours resulted in
the selective downregulation of KPNA2 mRNA expression;
the smallest effective dose of IFN-g was 10 U/ml (Po0.001).
There were no remarkable changes of KPNA2 mRNA ex-
pression in NHDF cells following IFN-g treatment (Figure 3a
and b). CHX treatment antagonized both IFN-g-dependent
upregulation and downregulation of KPNA2 mRNA expres-
sion in NHEKs (Figure 3c). No significant change in the
expression levels of other KPNA family members was
observed after IFN-g stimulation (data not shown).
Time-dependent regulation of KPNA2 protein expression by
TGF-b1 and IFN-c
TGF-b1 stimulation (5 ng/ml) of NHEKs resulted in the down-
regulation of KPNA2 protein expression after 24 hours
(Po0.001). Stimulation of NHEKs with 100 U/ml IFN-g initially
upregulated KPNA2 protein expression after 6 hours (Po0.01),
before the expression level gradually declined and was
completely suppressed after 48 hours (Po0.001), suggesting
dual regulation of KPNA2 protein expression by IFN-g (Figure 4).
This KPNA2 protein regulation by IFN-g and TGF-b corresponds
to the results obtained in the Northern blot analysis.
Suppression of KPNA2 promoter activity by IFN-c, not
by TGF-b1
To confirm the direct effects of TGF-b1 and IFN-g for KPNA2
transcription, NHEKs were transiently transfected with
KPNA2 promoter-luc plasmid pKPNA2-luc followed by
TGF-b and IFN-g inoculation in the culture medium, and
luciferase assays were performed. KPNA2 promoter activity
was significantly suppressed by IFN-g (100 U/ml) after 12 and
24 hours (Po0.001), but no significant promoter regulation
was observed in the early time point of IFN-g treatment or by
TGF-b stimulations (Figure 5).
Nuclear transport of IRF-1 with KPNA2
The induction of KPNA2 expression by IFN-g raised the
possibility that KPNA2 functions to transport IFN-g-inducing
transcription factors such as IRF-1, which is known to
be upregulated by IFN-g in NHEK cells, into the nucleus.
To test for an interaction between IRF-1 and KPNA2, we
co-transfected COS-7 cells with expression vectors coding for
myc-tagged IRF-1 and FLAG-tagged KPNA2, and performed
immunoprecipitation assays using anti-FLAG M2 agarose.
Immunoblotting analysis with both anti-myc antibodies
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Figure 3. Dual regulation of KPNA2 mRNA expression by IFN-c in NHEKs.
(a) Time-course analysis of KPNA2 mRNA expression regulated by IFN-g in
NHEK and NHDF cells. (b) Dose-dependent downregulation of KPNA2
mRNA expression in NHEK cells was evident after 24-hour incubations with
IFN-g. (c) CHX antagonized the effects of IFN-g on the regulation of KPNA2
mRNA expression after both 6 and 24 hours. Data are expressed as
means7SD from three independent experiments (**Po0.01 and ***Po0.001
compared with the initial expression level by one-way ANOVA).
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Figure 4. Regulation of KPNA2 protein expression by TGF-b1 and IFN-c.
NHEK cells were treated with either 5 ng/ml TGF-b1 or 100 U/ml IFN-g, and
subjected to Western blot analysis for KPNA2 expression. Data are expressed
as means7SD from three independent experiments (*Po0.05 and **Po0.01
compared with the initial expression level by one-way ANOVA).
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indicated that IRF-1 precipitated with anti-FLAG M2 agarose,
demonstrating an association between IRF-1 and KPNA2
(Figure 6a). Moreover, COS-7 cells co-transfected with the
myc-tagged KPNA2 and FLAG-tagged IRF-1 expression
vectors also revealed co-precipitation of IRF-1 with KPNA2
(Figure 6b). Interaction of endogenous KPNA2 and IRF-1 in
NHEK was then detected by immunoprecipitation using
anti-IRF-1 antibody and Western blotting using anti-
KPNA2 antibody (Figure 6c). These data suggest that KPNA2
might act to import IRF-1 into the nucleus in response to
IFN-g stimulation.
To investigate the roles of KPNA2 in IRF-1 localization, we
stimulated NHEK cells with 100 U/ml IFN-g with or without
KPNA2 knockdown with KPNA2-directed small interfering
RNA (siRNA). IRF-1, which was primarily observed in the
cytoplasm of NHEK cells without stimulation, translocated to
the nucleus after IFN-g stimulation (Figure 7). After KPNA2
knockdown, however, IRF-1 was retained in the cytoplasm
even after IFN-g stimulation, and some seemed to be
colocalized with KPNA2 (Figure 7), suggesting that IRF-1
localization into the nucleus following IFN-g treatment may
be mediated by KPNA2.
Possible roles of KPNA2 in keratinocyte differentiation
To investigate the effects of KPNA2 on NHEK gene
expression, we performed a single experiment of microarray
analysis in conditions with either a high or a low KPNA2
expression level. One hundred and fifty-one genes were
upregulated when KPNA2 was overexpressed in NHEK cells,
whereas 608 genes were downregulated as a result of KPNA2
knockdown. Fifty-four genes were modulated under both
conditions and therefore seemed to be putative genes
specifically regulated by KPNA2 expression (Table 1). Data
mining with the 54 genes was performed using keratinocyte
differentiation, a structural component of the epidermis, and
epidermal development as key terms. The database mining
extracted 10 genes, including involucrin, keratin 1, keratin
10, proline-rich protein 1A (SPRR1A), and small proline-rich
protein 1B (SPRR1B) (Figure 8a). To confirm the data of
the microarray analysis, real-time RT-PCR was performed for
involucrin mRNA expression in NHEKs. Involucrin mRNA
was significantly upregulated in the condition of high KPNA2
expression level and downregulated in that of KPNA2
knockdown (Figure 8b). We also confirmed no modulation
of GAPDH gene expression in the same mRNA samples used
in this study (data not shown). These data indicated that the
function of KPNA2 is, at least in part, to recruit transcriptional
regulators for keratinocyte differentiation to the nucleus.
DISCUSSION
In this paper, we demonstrated that among the KPNA
subunits in NHEK cells, the expression of KPNA2 is
specifically regulated by TGF-b1 and IFN-g. TGF-b1, which
is naturally expressed in the suprabasal cells of the epidermis,
induces reversible growth arrest at the G1 phase of the
cell cycle (Shipley et al., 1986; Alexandrow et al., 1995),
but does not contribute to terminal differentiation (George
et al., 1990; Arany et al., 1996). In contrast, IFN-g, which
is primarily produced and secreted by Langerhans cells
in normal epidermis, induces irreversible growth arrest in
cultured keratinocytes (Saunders and Jetten, 1994) and
promotes aberrant terminal differentiation (Brysk et al.,
1991; Tamai et al., 1995).
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Figure 5. Regulation of KPNA2 promoter activity by IFN-c. NHEK cells were
transfected with KPNA2 promoter expression vector and treated with 5 ng/ml
TGF-b1 or 100 U/ml IFN-g for 12 and 24 hours, and subjected to luciferase
assay. Data are expressed as means7SD (*Po0.001 compared with the IFN-g
or TGF-b1 absent expression level by one-way ANOVA).
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Figure 6. Evidence for KPNA2 association with IRF-1. (a) FLAG-tagged
KPNA2 (KPNA-FLAG) and myc-tagged IRF-1 (IRF-1-myc) expressed in
COS-7 cells were co-precipitated with anti-FLAG M2-agarose. IRF-1-myc
was detected with both anti-myc and anti-IRF antibodies in the precipitants.
(b) The association of IRF-1-FLAG with KPNA2-myc was also demonstrated
by immunoprecipitation with anti-FLAG M2-agarose, followed by
immunoblotting with anti-myc antibodies. (c) Endogenous association
of IRF-1 and KPNA2 in NHEK. NC: negative control.
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Previous studies have revealed that transcription factors
such as Myc, NF-kB (Nadler et al., 1997), and Epstein-Barr
virus nuclear antigen (EBNA) (Fischer et al., 1997) are target
proteins of KPNA2. The expression and nuclear localization
of c-myc, an essential transcription factor required to
maintain cell growth in the basal layer of the epidermis
(Pietenpol et al., 1990; Alexandrow et al., 1995), are rapidly
downregulated when keratinocytes are treated with TGF-b1
(Coffey et al., 1988), resulting in growth arrest in the G1
phase of the cell cycle (Pietenpol et al., 1990). Therefore, we
speculate that the inhibition of proliferation observed in
NHEK cells following TGF-b1 and IFN-g treatment may be a
result of the downregulation of KPNA2 and impaired nuclear
import of c-myc.
Whereas TGF-b1 caused only the downregulation of
KPNA2 expression, IFN-g treatment induced KPNA2 expres-
sion within an initial 12 hours followed by downregulation
after 24 hours at both mRNA and protein levels. A previous
study showed that transglutaminase and cornifin, both of
which are marker genes of keratinocyte differentiation, were
upregulated by IFN-g in 12–36 hours, indicating the promo-
tion of keratinocyte terminal differentiation (Saunders and
Jetten, 1994). The parallel induction of KPNA2 and kerati-
nocyte differentiation marker genes by IFN-g suggest that
increased nuclear entry of KPNA2-mediated signals may be
involved in the keratinocyte differentiation.
IFN-g directly inhibited KPNA2 promoter activity followed
by suppression of KPNA2 expression at both mRNA and
protein levels. However, early upregulation by IFN-g and
downregulation by TGF-b1 were not observed by the
KPNA2 promoter assay. These results may be explained by
the secondary effect caused by induced changes in growth
arrest and keratinocyte differentiation, or this 1 kb promoter
region may not contain a cis-element responsible for the
modulation.
CHX antagonized the effects of both TGF-b1 and IFN-g on
KPNA2 mRNA expression, indicating that protein synthesis
was required for KPNA2 regulation by these cytokines. There
is evidence that, following IFN-g activation, STAT-1 enters
the nucleus via a mechanism that is KPNA1/NPI-1 dependent
and KPNA2/Rch1 independent (Sekimoto et al., 1997). This
STAT1/KPNA1 complex may regulate the protein synthesis
required for the modulation of KPNA2 by IFN-g.
In this study, we also demonstrated for the first time
that KPNA2 physically interacts with IRF-1, which is
specifically induced in NHEK cells by IFN-g stimulation,
and regulates the nuclear entry of IRF-1. Whereas IRF-1
mRNA expression remains high after treatment of keratino-
cytes with IFN-g after 48 hours (Odanagi et al., 2004), KPNA2
expression was suppressed at this time point, suggesting
that KPNA2 may play a pivotal role, if not exclusive, for the
fine-tuning of IFN-g/IRF-1-dependent signal transduc-
tion during epidermal differentiation. A single microarray
experiment with mRNA from KPNA2-overexpressed/
downregulated NHEKs extracted a putative list of 10 genes
relating to keratinocyte differentiation, suggesting again that
KPNA2 may function for the nuclear entry of signals for
keratinocyte differentiation. Repeated experiments, however,
must be performed to provide a final list of the genes
regulated by KPNA2.
Although KPNA2 overexpression resulted in induction of
several keratinocyte differentiation-marker genes, we could
not observe apparent morphological changes as seen in
differentiated keratinocytes. Taken together, KPNA2 seems to
be involved in keratinocyte differentiation, but may not be
sufficient for the full-differentiation induction by itself.
Aberrant expression of KPNA2 induced by IFN-g in the
epidermis may be involved in disorders such as psoriasis, in
which both proliferation and differentiation of epidermal
keratinocytes are disorganized. Further elucidation of the
functions of KPNAs in epidermal keratinocytes during
physiological and pathological conditions may provide
clues for developing novel therapeutic approaches to skin
diseases.
MATERIALS AND METHODS
Reagents
Recombinant human TGF-b1 and recombinant human IFN-g were
purchased from Roche (Mannheim, Germany). Anti-human KPNA2
goat polyclonal antiserum, anti-human IRF-1 rabbit polyclonal
antiserum, and horseradish peroxidase-conjugated donkey anti-goat
IgG were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-myc-tag monoclonal mouse antibodies and anti-FLAG
mouse antibodies were obtained from MBL (Nagoya, Japan) and
Sigma-Aldrich (St Louis, MO), respectively. Finally, horseradish
peroxidase-conjugated donkey anti-rabbit IgG and horseradish
peroxidase-conjugated sheep anti-mouse IgG were purchased from
Amersham (Arlington Heights, IL).
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Figure 7. KPNA2-mediated nuclear import of IRF-1 after IFN-c stimulation.
To detect the localization of IRF-1 in NHEK cells, immunohistochemistry was
performed. Without IFN-g stimulation, IRF-1 was mainly located in the
cytoplasm (IFN-g () scramble and IFN-g () si KPNA2), whereas IRF-1
accumulated in the nucleus after IFN-g stimulation (100 U/ml) for 12 hours
(IFN (þ ) scramble). IRF-1 in NHEK cells pretreated with siRNA, however,
remained in the cytoplasm. Bar¼ 50 mm.
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Table 1. Lists of genes upregulated in response to
KPNA2 overexpression and downregulated by siRNA-
mediated KPNA2 knockdown
Gene name Systematic name
CDSN L20815
KLK7 NM_005046
DEFB1 NM_005218
GJB6 NM_006783
BF337308 BF337308
ZD52F10 NM_033317
KPNA2 NM_002266
KRT23 NM_173213
TUBB2 NM_001069
FABP5 NM_001444
SERPINB3 NM_006919
SPINK5 NM_006846
HOP NM_139211
AF113013 AF113013
FABP5 NM_001444
KRT1 NM_006121
SLPI NM_003064
A_23_P247 A_23_P247
SPRR1A NM_005987
KLK11 NM_144947
SERPINB4 NM_002974
GLTP NM_016433
TMEM45A NM_018004
SERPINB7 NM_003784
RDH12 NM_152443
THC2172764 THC2172764
ANKRD35 NM_144698
ANKRD22 NM_144590
C1orf42 NM_019060
LOC346910 XM_294456
DSC1 NM_004948
SPRR1B NM_003125
CENTB5 NM_030649
RHCG NM_016321
KLK10 NM_002776
ENST00000238875 ENST00000238875
A_24_P290087 A_24_P290087
KRT16 NM_005557
SLPI NM_003064
KRT10 NM_000421
SLC6A14 NM_007231
SPRR2B NM_006945
S100A9 NM_002965
Table 1. continued
Gene name Systematic name
MGC13102 NM_032323
IVL NM_005547
LOC344332 XM_293018
FLJ21511 NM_025087
A_24_P821693 A_24_P821693
UNQ467 NM_207392
SPRR2C M21539
LOC144501 NM_182507
KLK5 NM_012427
IL1F5 NM_012275
PGLYRP4 NM_020393
KPNA2, karyopherin a2; siRNA, small interfering RNA.
Fifty-four genes were identified by microarray analysis.
Upregulated genes
Downregulated genes
by KPNA2
siKPNA2
by KPNA2 and
151 genes
by siKPNA2
608 genes
54 genes (Table 1)
Common genes
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Keratinocyte differentiation,
structural constitute of epidermis
and epidermis development
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Figure 8. Keratinocyte differentiation is modulated by KPNA2 expression.
(a) To evaluate the effects of the KPNA2 expression level on NHEK gene
expression, microarray analysis was performed. Ten of these genes, which are
listed in the figure, were extracted by data mining in the database of identified
genes using keratinocyte differentiation, structural component of the
epidermis, and epidermis development as key terms. (b) Expression analysis of
involucrin and keratin 5 by quantitative real-time PCR in the condition of high
or low KPNA2 expression levels. Data are expressed as means7SD from
three independent experiments (*Po0.05).
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Cell culture
NHEKs obtained from neonatal foreskin were purchased from
Clonetics (San Diego, CA) and Cascade Biologics (Portland, OR).
The cells were propagated in keratinocyte growth medium
(Clonetics) containing recombinant human EGF (0.1 mg/ml), insulin
(0.5 mg/ml), hydrocortisone (0.5 mg/ml), gentamicin (50 mg/ml), am-
photericin B (50 ng/ml), and bovine pituitary extract (0.1 mg/ml), or in
standard medium containing 0.06 mmol/ml Ca2þ (Epilife-KGM;
Cascade Biologics) supplemented with human EGF (0.1 mg/ml),
insulin (10 mg/ml), hydrocortisone (0.5 mg/ml), gentamicin (50 mg/ml),
amphotericin B (50 ng/ml), and 4% bovine pituitary extract at 371C
under 5% CO2–95% air. Cells were passed by trypsinization and
50–60% confluents of the keratinocytes were used for each
experiment at the third or fourth passage.
HaCaT, an immortalized, non-tumorigenic keratinocyte cell line
(kindly provided by Dr Husenig), NHDF, and COS-7 cells were
cultured in DMEM (Nakarai, Tokyo, Japan) containing 10% fetal
bovine serum at 371C under 5% CO2–95% air. NHDFs at the fifth
passage were used for the experiments. Before cytokine stimulation,
sub-confluent NHDF cells were incubated for 24 hours in serum-free
medium. Various doses of TGF-b1 or IFN-g were then added to the
medium and the cells were incubated as indicated. The study was
conducted according to the Declaration of Helsinki Principles.
RNA isolation and Northern blot analysis
Total RNA was extracted from cells using an RNA isolation kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. mRNA (15–20 mg) from each sample were electrophore-
sed on 1% formaldehyde/agarose gels, transferred to nylon
membranes (Zeta-Probe blotting membrane, Bio-Rad, Hercules,
CA), and immobilized by shortwave UV irradiation (UV-Stratalinker
1800, Stratagene, La Jolla, CA). All KPNA probes were generated by
RT-PCR, sequenced, and labeled with 32P using a random prime
labeling kit (Stratagene). Blots were hybridized with 32P-labeled
cDNA probes for KPNA1, KPNA2, KPNA3, KPNA4, and KPNA5
overnight at 431C in 50% deionized formamide and re-hybridized
with GAPDH. The filters were washed in 2 standard sodium
citrate and 0.1% SDS at room temperature and exposed to film at
801C for approximately 24 hours for KPNA2, KPNA3, and KPNA4
or for 1 week for KPNA1 and KPNA5. Hybridization signals were
quantified with a densitometer. The differences were statistically
examined using one-way analysis of variance (ANOVA).
Western blot analysis
Cells were washed twice with cold phosphate-buffered saline (PBS)
and then lysed in radioimmunoprecipitation assay buffer (20 mM
Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, and 0.5 M
EDTA at pH 7.4), supplemented with protease inhibitor cocktail
(complete mini, Roche). After ultrasonication and removal of
insoluble cell debris, the protein concentration in the supernatant
was determined with Bio-Rad Protein Assay Dye Reagent Concen-
trate (Bio-Rad). For Western analysis, 100 mg of the proteins were
electrophoresed on a 10% SDS polyacrylamide gel. After electro-
phoresis, the proteins were transferred to nitrocellulose membranes
(Hybond-P, Amersham) in transfer buffer containing 100 mM Tris-
HCl, 192 mM glycine, and 20% methanol. Residual binding sites on
the membranes were blocked with 2% skim milk in Tris-buffered
saline overnight at room temperature. The blots were incubated with
primary antibodies for at least 1 hour at room temperature, washed
five times (5 minutes each) with Tris-buffered saline containing
0.05% Tween 20, and incubated with horseradish peroxidase-
conjugated secondary antibodies for 1 hour at room temperature.
After washing, the membranes were developed with an enhanced
chemiluminescence system (ECL-plus; Amersham). Normalized
densitometric values for the individual lanes in three independent
experiments were averaged; data are represented as the means7SD.
Construction of KPNA2 promoter-luciferase plasmid
PCR primers for amplification of KPNA2 promoter regions were
designed to obtain 50 flanking DNA at positions from 1 to 1,000.
PCR-amplified fragments were then inserted into the KpnI-HindIII
site of the pGL3-basic vector (Promega, San Luis, CA) to generate
pKPN2-luc plasmid. The sequences inserted into pGL3-basic vector
were confirmed by direct sequencing.
Transient transfection and luciferase assay
NHEK cells placed into 12-well plates were transfected with 0.43 mg
of pKPN2-luc plasmid and 0.17 mg of pRL-TK vector using TransIT-
LT1 (Mirus, Bienne, Bern, Switzerland). At the time of the
transfection, 5 ng/ml of TGF-b1 or 100 U/ml of IFN-g were added
into the medium and harvested by 100 ml of passive cell lysis buffer
(Promega) after each time course. The dual luciferase reporter assay
was performed by a Dual-Glo luciferase Assay kit (Promega). pRL-TK
vector was used as internal control, and data were normalized by
Renilla luciferase luminescence intensity. The experiments were
performed in triplicate, and the differences were statistically
examined using one-way ANOVA.
Construction of KPNA2 and IRF-1 expression vectors, and
siRNA-mediated knockdown of KPNA2
To create the pCY4B-KPNA2, pCAGIp-FLAG-KPNA2, pCAGIp-myc-
KPNA2, pCAGIp-FLAG-IRF-1, and pCAGIp-myc-IRF-1 expression
vectors, full-length human KPNA2 and IRF-1 cDNAs were generated
by RT-PCR with PfuUltra High-Fidelity DNA polymerase
(Stratagene). The PCR products were sequenced and their
sizes were verified by agarose gel electrophoresis. The products
were then cut from the gel, purified using a QIAquick gel extrac-
tion kit (Qiagen), and cloned into the pCR-Blunt-TOPO vector
(Invitrogen, Carlsbad, CA). To complete the recombination sites, an
adapter PCR was performed as described in the Gateway
manual (Invitrogen). The purified PCR products were also cloned
into the pENTER/SD/D-TOPO vector (Invitrogen), and cDNA
plasmids were converted into other expression vectors using the
Gateway LR reaction (Invitrogen). The medical ethical committee of
Osaka University Graduate School of Medicine approved all
described studies.
siRNAs specific for KPNA2 and its control stealth siRNA were
designed and obtained from Invitrogen. We performed KPNA2
knockdown studies with siRNA, which ensured more than 50%
suppression of KPNA2 mRNA and protein.
Immunoprecipitation analysis
COS-7 cells transiently transfected using FuGene 6 (Roche) with
pCAGIp-FLAG-KPNA2 and pCAGIp-myc-IRF-1, or pCAGIp-FLAG-
IRF-1 and pCAGIp-myc-KPNA2 were lysed in ice-cold EBL buffer
(150 mM NaCl, 50 mM N-2-hydroxyethylpiperazine-N0-2-ethanesul-
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fonic acid, 5 mM EDTA, 0.1% Nonidet P-40 at pH 7.5 supplemented
with protease inhibitors) for 15 minutes. After precleaning
with mouse IgG agarose (Santa Cruz Biotechnology), the
lysates were immunoprecipitated with anti-FLAG M2-agarose
(Sigma) and extensively washed. Immunoprecipitates were analyzed
by Western blotting with anti-myc, anti-IRF-1, and anti-KPNA2
antibodies.
NHEK cells cultured on 100 mm dishes were lysed in PBS
containing 0.5% Triton X and 5 mM EDTA with protease inhibitor
cocktail and phosphatase inhibitor (Sigma). Cell extracts were
incubated overnight with 2 mg of anti-IRF-1 antibodies or in the
absence of antibodies at 41C. The immunoprecipitates were
collected on protein A–Sepharose beads (Amersham) for 4 hours at
41C. After washing five times with lysis buffer, proteins bound to
Sepharose beads were eluted by boiling in sample buffer. Western
blotting was performed with anti-KPNA2 antibodies.
Immunohistochemistry
NHEK cells were grown on tissue-culture-treated slides (Falcon,
Becton Dickinson, Franklin Lakes, NJ) and transfected with or
without KPNA2 siRNAs 24 hours before stimulation with 100 U/ml
IFN-g. After about 12 hours, cells were fixed with 4% paraformalde-
hyde at room temperature for 1 hour. Cells were permeabilized using
0.1% Triton X-100 in PBS for 3 minutes. Slides were washed in PBS,
and nonspecific sites were blocked with 2% skim milk in PBS
overnight before the slides were incubated with anti-human IRF-1
rabbit polyclonal antibodies (1:500) and anti-human KPNA/Rch1
mouse mAbs (BD Biosciences, San Jose, CA) (1:1,000). Subse-
quently, cells were labeled with Alexa Fluor 488 donkey anti-rabbit
IgG and Alexa Fluor 546 goat anti-mouse IgG secondary antibodies
(Molecular Probes, Eugene, OR) for 3 hours. Cells were then washed
five times with PBS. Finally, the slides were stained with 40,6-
diamidino-2-phenylindole for 10 minutes at room temperature and
mounted with Vectashield anti-fade solution (Vector Laboratories
Inc., Burlingame, CA).
Microarray analysis
NHEK cells were transfected with the pCY4B or pCY4B-KPNA2
expression vectors using TransIT-LT1 (Mirus) and control or KPNA2
stealth siRNA using TransIT-TKO (Mirus). Total RNA was extracted
with an RNA isolation kit (Qiagen). The Whole Human Oligo
Microarray (Agilent Technology, Palo Alto, CA) included 44,287
clones printed on a glass slide.
For hybridization, 500 ng of total RNA was labeled with Cy3 or
Cy5 monoreactive dyes using a Low RNA Fluorescent Linear
Amplification kit (Agilent Technology). Cy3- and Cy5-labeled cDNA
probes were cleaned with RNeasy mini spin columns (Qiagen). The
purified probes were resuspended in hybridization buffer, and
hybridization was performed at 601C for 17 hours. The microarray
slide was washed once with 6 standard sodium citrate and
0.005% Triton X-102 at room temperature for 10 minutes, and once
with 0.1 standard sodium citrate and 0.005% Triton X-102 at 41C
for 5 minutes. Microarray scannings were performed using the
Agilent Technologies Microarray Scanner, and statistical analysis
was performed using two-tailed t-tests (Po0.01). Data mining in the
gene database was performed with keratinocyte differentiation,
epidermal structural components, and epidermis development as
search terms.
Quantitative real-time PCR
The NHEK cells that were used for microarray analysis were also
examined by quantitative real-time PCR. After RNA isolation, RT
reactions were performed using SuperScript III (Invitrogen). All
TaqMan probes (KPNA2: Hs 00818252g1; GAPDH:
Hs99999905m1; involucrin: Hs00846307s1) were ordered from
‘‘Gene Expression Assays’’ (Applied Biosystems Inc., Foster City,
CA). GAPDH was used as an internal control for all PCR
amplification reactions. Relative mRNA expression was quantified
using the comparative Ct (DCt) method and expressed as 2
DDCt .
Each assay was carried out in triplicate and expressed as mean7SD.
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